| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.52T | 2.61T | 2.45T | 2.90T | 2.77T | 2.29T |
| Gross Profit | 717.34B | 725.48B | 499.69B | 820.93B | 873.86B | 771.20B |
| EBITDA | 289.46B | 321.64B | -258.31B | 199.08B | 388.68B | 306.28B |
| Net Income | 9.69B | 38.59B | -311.84B | 6.99B | 162.13B | 46.04B |
Balance Sheet | ||||||
| Total Assets | 3.33T | 3.44T | 3.93T | 4.17T | 4.31T | 3.99T |
| Cash, Cash Equivalents and Short-Term Investments | 202.65B | 209.84B | 217.45B | 305.84B | 389.42B | 360.92B |
| Total Debt | 1.25T | 1.29T | 1.56T | 1.46T | 1.35T | 1.35T |
| Total Liabilities | 2.27T | 2.37T | 2.77T | 2.68T | 2.61T | 2.51T |
| Stockholders Equity | 885.87B | 900.79B | 965.75B | 1.17T | 1.22T | 1.02T |
Cash Flow | ||||||
| Free Cash Flow | 137.03B | 102.56B | -204.19B | -31.96B | 64.25B | 253.65B |
| Operating Cash Flow | 269.28B | 233.03B | -51.32B | 111.62B | 171.72B | 374.46B |
| Investing Cash Flow | -48.54B | 79.90B | -112.24B | -19.41B | -115.42B | -177.39B |
| Financing Cash Flow | -281.65B | -295.45B | 49.25B | -178.50B | -81.39B | -39.97B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥1.64T | 13.74 | 7.48% | 3.15% | 3.55% | 95.65% | |
72 Outperform | ¥687.97B | 15.27 | 19.69% | 3.41% | 10.06% | 18.03% | |
69 Neutral | $9.17T | 17.98 | 10.87% | 2.16% | 3.77% | 0.35% | |
62 Neutral | ¥495.03B | 60.98 | 1.08% | 3.53% | -1.94% | -84.08% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | $703.12B | 8.29 | 8.79% | 2.64% | -1.64% | ― | |
54 Neutral | $1.10T | 10.09 | 1.09% | 3.97% | -11.50% | 25.86% |
Sumitomo Chemical Co., Ltd. is a diversified chemical company based in Japan, operating in sectors such as agrochemicals, pharmaceuticals, and petrochemicals, with a focus on innovative solutions and sustainable practices.
Sumitomo Chemical Co., Ltd. reported a share of loss of ¥17,513 million due to the poor financial performance of Rabigh Refining and Petrochemical Company, an equity-method affiliate. Additionally, the company recorded a foreign exchange gain of ¥15,232 million, attributed to fluctuations in foreign exchange rates impacting assets and liabilities in foreign currencies.
The most recent analyst rating on (JP:4005) stock is a Hold with a Yen510.00 price target. To see the full list of analyst forecasts on Sumitomo Chemical Co stock, see the JP:4005 Stock Forecast page.
Sumitomo Chemical announced variances between its forecasted and actual financial results for the second quarter ending March 31, 2026, with stronger than expected sales of ORGOVYX in North America and reduced expenses leading to higher core operating and net income. Additionally, the company revised its full-year forecast, anticipating continued strong performance in North America and incorporating impacts from the partial sale of shares in Petro Rabigh, which is expected to positively affect its financial outcomes.
The most recent analyst rating on (JP:4005) stock is a Hold with a Yen510.00 price target. To see the full list of analyst forecasts on Sumitomo Chemical Co stock, see the JP:4005 Stock Forecast page.
Sumitomo Chemical Co. reported its consolidated financial results for the second quarter of fiscal year 2025, showing a decline in sales revenue by 11.8% compared to the previous year. Despite this, the company experienced a significant increase in core operating income by 268.8%, indicating improved recurring earnings capacity. The financial results reflect a challenging market environment but also highlight the company’s ability to enhance operational efficiency. The exclusion of XUYOU Electronic Materials (Wuxi) Co., Ltd. from consolidation and a revision of financial forecasts for the fiscal year were noted, impacting stakeholders’ expectations.
The most recent analyst rating on (JP:4005) stock is a Hold with a Yen510.00 price target. To see the full list of analyst forecasts on Sumitomo Chemical Co stock, see the JP:4005 Stock Forecast page.
Sumitomo Chemical Co., Ltd. is set to make Tanaka Chemical Corporation a wholly-owned subsidiary through a simplified share exchange, effective January 30, 2026. This strategic move aims to strengthen Sumitomo’s position in the rechargeable battery market by leveraging Tanaka’s expertise in cathode materials, aligning with Sumitomo’s growth strategy and enhancing its technological capabilities in response to increasing demand for energy-efficient solutions.
The most recent analyst rating on (JP:4005) stock is a Hold with a Yen510.00 price target. To see the full list of analyst forecasts on Sumitomo Chemical Co stock, see the JP:4005 Stock Forecast page.
Sumitomo Chemical Co., Ltd. has completed the sale of a portion of its Class A ordinary shares in Rabigh Refining and Petrochemical Company (Petro Rabigh) to Saudi Aramco, reducing its stake from 37.5% to 15%. This transaction makes Saudi Aramco the largest shareholder of Petro Rabigh, holding nearly 60% of the Class A shares. The move is part of a strategic effort to improve Petro Rabigh’s financial structure and support its turnaround plan. Sumitomo Chemical and Saudi Aramco have also subscribed to new Class B ordinary shares issued by Petro Rabigh, which will aid in prepaying debts and reducing accumulated losses. The financial impact on Sumitomo Chemical includes a projected profit of approximately 35 billion yen before tax for the third quarter of the fiscal year ending March 31, 2026, despite recording a loss on valuation of the newly acquired Class B shares.
The most recent analyst rating on (JP:4005) stock is a Hold with a Yen510.00 price target. To see the full list of analyst forecasts on Sumitomo Chemical Co stock, see the JP:4005 Stock Forecast page.
Sumitomo Chemical Co., Ltd. has announced the partial sale of its shares in Rabigh Refining and Petrochemical Company (Petro Rabigh) to Saudi Aramco. This move is part of a strategic plan to enhance Petro Rabigh’s financial structure and support its turnaround efforts. The proceeds from the sale will be reinvested into Petro Rabigh, with both Sumitomo Chemical and Saudi Aramco subscribing to a new class of non-voting ordinary shares. This capital restructuring aims to eliminate accumulated losses without affecting Petro Rabigh’s operations or financial results. The shareholding ratio will shift significantly, with Saudi Aramco increasing its stake to 60%, while Sumitomo Chemical’s shareholding will decrease to 15%. The financial impact on Sumitomo Chemical is still under review, with no immediate changes to its financial forecast.
The most recent analyst rating on (JP:4005) stock is a Hold with a Yen428.00 price target. To see the full list of analyst forecasts on Sumitomo Chemical Co stock, see the JP:4005 Stock Forecast page.